AiMOGA Robotics, a Chery brand, unveiled Mobo, its first consumer-grade humanoid robot designed for home companionship, at the 2026 Chery International User Summit. Powered by AiMOGA's proprietary AI system MoAgent, Mobo can interpret complex commands, navigate home environments, and remember family preferences while ensuring privacy. The launch marks AiMOGA's expansion from commercial to consumer markets, leveraging Chery's automotive R&D and supply chain expertise. Global pre-orders for Mobo opened during the summit, with AiMOGA showcasing a broader robot portfolio for various real-world applications.
AiMOGA Robotics' launch of the Mobo home companion robot comes as the Technology sector on Pluang shows a broad decline, with only 11 of 150 US stocks rising. For readers following this sector, here is Pluang's market snapshot as of Oct 17, 2026 23:11 WIB: Okta, Inc. (OKTA) traded at USD 187.26 with a 10.20% drop and 91% sell order activity; Super Micro Computer Inc (SMCI) was at USD 31.63, down 9.86% but with 73% buy order activity; DigitalOcean Holdings Inc (DOCN) stood at USD 98.69, down 9.85% with balanced buy/sell orders.
Chery Auto will showcase its purpose-built Level 4 (L4) Robotaxi at the 2026 Chery International User Summit and sign a strategic cooperation agreement with UAE-based K2. The Robotaxi offers a fully driverless passenger experience from booking to rid...
AiMOGA Robotics, a Chery brand, unveiled Mobo, its first consumer humanoid robot designed for home companionship, at the 2026 Chery International User Summit. Mobo uses advanced AI to understand complex commands, navigate home environments, and remem...
AiMOGA Robotics, a Chery brand, will debut Mobo, its first consumer-grade humanoid robot designed as a home companion, at the 2026 Chery International User Summit in Wuhu, China. Mobo features advanced AI for understanding complex commands, spatial a...
AiMOGA Robotics, a brand under Chery, introduced Mobo, its first consumer-grade humanoid robot designed as a family companion, at the 2026 Chery International User Summit. Mobo operates with AiMOGA's proprietary MoAgent AI, enabling it to understand ...
Ascendis Pharma announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of TransCon CNP (navepegritide), a once-weekly treatment for achondroplasia in children aged two and older with open growth plates...
